I don't want a partnership, and would rather dilution at a later time.
lets use our funds we have to dose a patient and get further on in the clinical pathway before we go looking for partnerships. I feel a partner would want a huge chunk of the IP at this stage. We haven't even determined the safety profile(P1) yet for breast cancer.
Ann: Race Board and Management Team Changes, page-351
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.69 |
Change
0.000(0.00%) |
Mkt cap ! $288.0M | |||
| Open | High | Low | Value | Volume |
| $1.69 | $1.69 | $1.65 | $179.8K | 108.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1437 | $1.65 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.74 | 3313 | 1 |
View Market Depth
| Last trade - 15.58pm 03/10/2024 (20 minute delay) ? |
| RAC (ASX) Chart |